FDA approves lung cancer drug Zykadia
WASHINGTON, D.C. (Press Release) — U.S. Senator Michael Bennet, D-Colorado, has C welcomed the U.S. Food and Drug Administration’s (FDA) approval of another breakthrough drug – this time for a lung cancer drug manufactured by Novartis. The drug, known as Zykadia, will help treat patients with a certain type of late-stage non-small cell lung cancer. […]
FDA approves lung cancer drug Zykadia Read More »
Science, Medicine, & Education, USA



